Results 251 to 260 of about 4,777,622 (429)

Advances in radiotherapy in the treatment of esophageal cancer. [PDF]

World J Clin Oncol
Rao V, Singh S, Zade B.
europepmc   +1 more source

Clinical study on jejunal movement after radical operation for esophageal cancer.

, 1986
Kiyoshi Nagata
openalex   +2 more sources

Interview with the World Class Authorities Frontiers of Cancer Research: An exclusive interview with Professor Luis Diaz

Annals of Gastroenterological Surgery, EarlyView.
This is the second installment in the series, “The Interview with the World‐Class Authorities.” We are honored to welcome Prof. Luis Diaz, the Director of the Division of Solid Tumor Oncology at Memorial Sloan Kettering Cancer Center and Editor‐in‐Chief of Cancer Discovery. Prof.
Haruna Takeda, Koshi Mimori, Masanobu Oshima, Ken Shirabe, Yuko Kitagawa   +4 more
wiley   +1 more source

TGIF1 overexpression promotes glioma progression and worsens patient prognosis

Cancer Medicine, Volume 11, Issue 24, Page 5113-5128, December 2022., 2022
This study is the first to comprehensively analyze and reveal TGIF1, as a new oncogene, is closely related to the malignancy‐related phenotype of glioma, and that TGIF1 could be an independent risk factor for poor prognosis of glioma, which is expected to become a new target for individualized treatment of glioma patients.
Baoya Wang, Qiong Ma, Xuelin Wang, Kunshan Guo, Zhendong Liu, Gang Li   +5 more
wiley   +1 more source

Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells. [PDF]

Front Immunol
Zhang Y, Wan Y, Li J, Ju S, Tong X, Wu J, Wu H, Zhang L, Shao S, Wang Y, Guo L, Zhao J, Cao L, Jiang D.   +13 more
europepmc   +1 more source

A history of gastrectomy is a risk factor for choledocholithiasis in patients undergoing cholecystectomy: A single center retrospective study

Annals of Gastroenterological Surgery, EarlyView.
This retrospective study suggests that gastrectomy is a risk factor for choledocholithiasis. Especially in terms of the differences in reconstruction methods, the median time from gastrectomy to development of choledocholithiasis was 5.5 years for Roux‐en‐Y, which was significantly faster than 20 years for Billroth I and 35 years for Billroth II ...
Yuki Matsui, Daisuke Hashimoto, So Yamaki, Kazuki Matsumura, Hidetaka Miyazaki, Yuji Ikeda, Denys Tsybulskyi, Thanh Sang Nguyen, Sohei Satoi   +8 more
wiley   +1 more source

Identification of pyroptosis‐related gene prognostic signature in head and neck squamous cell carcinoma

Cancer Medicine, Volume 11, Issue 24, Page 5129-5144, December 2022., 2022
We built and verified a risk model for HNSCC prognosis using 7 pyroptosis‐related signature genes, which could facilitate the implementation of the HNSCC treatment. Abstract Background Head and neck squamous cell carcinoma (HNSCC) is a life‐threatening disease with poor prognosis.
Zhanzhan Li, Lin Shen, Yanyan Li, Liangfang Shen, Na Li   +4 more
wiley   +1 more source

Current Advances in Immunotherapy Management of Esophageal Cancer. [PDF]

Cancers (Basel)
Pyreddy S, Kim S, Miyamoto W, Talib Z, GnanaDev DA, Rahnemai-Azar AA.   +5 more
europepmc   +1 more source

Lymph flow and lymph node metastasis of the thoracic esophageal cancer.

, 1987
Masamichi Baba, Kazunao KUROSIMA, Gen Tanabe, Shoji Natsugoe, Heiji Yoshinaka, Yuzo KAWASAKI, Atushi MIRE, Hiroshi MURE, Toshitaka Fukumoto, Masahiro MATUNO, Takashi Aikou, T Kajisa, Hisaaki Shimazu, Mitsumasa Nishi   +13 more
openalex   +2 more sources

Malignant tracheoesophageal fistula in patients with esophageal cancer [PDF]

, 1993
Juergen M. Gschossmann, James A. Bonner, Robert L. Foote, Edward G. Shaw, James A. Martenson, John Q. Su   +5 more
openalex   +1 more source